Medicine should be taught in high school

[derail]

Something that amazes me is that no one has sued a doctor for removing their foreskin when they were an infant. Given the victim culture in the US I'd have thought they would stand a good chance of winning.

[/derail]

I think you may have just inadvertently created a new brach of the legal profession.:D
 
Yes it has been tested as well as we know the reason drug resistance is more likely when you under-treat an infection.

I've actually done this demonstration / experiment with my 2nd year micros. The key is the mechanism of action: many antibiotics, such as beta-lactams, don't kill bacteria directly - chemicals that do that are called 'microbicidals. ' Instead, many merely prevent them from functioning normally, such as slowing down growth. They may take two weeks to die under prolonged exposure, and the body is doing the heavy lifting with CTLs. The antibiotic is 'buying the body time,' or 'giving the body some space,' rather than killing the bacteria directly.

If you stop the exposure prematurely, all you've done is delay their growth temporarily, trigger plasmid distribution to ensure even the non-resistant ones are resistant now, all without giving the immune system enough time it needs to crack the denser colonies. It makes things much worse.

As you say: full course is not guaranteed to totally eliminate the gribblies, but it does improve the odds significantly, which is why it's recommended as part of reducing global resistance risk. It's more important if the patient has weak immunity: seniors, seriously ill, &c.


An above poster was asking about whether giving antibiotics for one bacteria can have consequences for resistance in others... that depends firstly on whether the other bacteria are vulnerable to the particular antibiotic's mechanism of action. In this sense wide-spectrum antibiotics are more likely to have cross-impact. It also depends on the location and colonizing properties of the other gribbly. Some systemic antibiotics will not contact integument flora, for example, and vice-versa: topicals may not penetrate, depending on formulation.



Another poster was asking about whether bacteria can be harmless in one location, but harmful in another. To answer this, you have to start by understanding that there shouldn't be bacteria 'inside' the body at any time. The respiratory surface is just a continuation of the skin, as is the bowel, and mucousy regions such as they eye and the urinary tract below the bladder. So these are considered 'outside'. It's normal to find bacteria here, and this is not surprisingly where most infections occur.

If bacteria is present 'inside' the body - meaning in tissues such as muscle, bone, blood, or other organ tissues, the patient has a big problem. The most common way bacteria get from 'outside' to 'inside' is some sort of wound that punctures the integument. Another route is mucous membranes, whose surfaces are unfortunately permeable to particles of this size.
 
blutoski said:
I've actually done this demonstration / experiment with my 2nd year micros. The key is the mechanism of action: many antibiotics, such as beta-lactams, don't kill bacteria directly - chemicals that do that are called 'microbicidals. ' Instead, many merely prevent them from functioning normally, such as slowing down growth. They may take two weeks to die under prolonged exposure, and the body is doing the heavy lifting with CTLs. The antibiotic is 'buying the body time,' or 'giving the body some space,' rather than killing the bacteria directly.

If you stop the exposure prematurely, all you've done is delay their growth temporarily, trigger plasmid distribution to ensure even the non-resistant ones are resistant now, all without giving the immune system enough time it needs to crack the denser colonies. It makes things much worse.

Those are situations where the person gets sick again, though, or stays sick, right?

If the person recovers and doesn't immediately relapse, is an incomplete course more harmful when it comes to resistance than a full course?
 
I've actually done this demonstration / experiment with my 2nd year micros. The key is the mechanism of action: many antibiotics, such as beta-lactams, don't kill bacteria directly - chemicals that do that are called 'microbicidals. ' Instead, many merely prevent them from functioning normally, such as slowing down growth. They may take two weeks to die under prolonged exposure, and the body is doing the heavy lifting with CTLs. The antibiotic is 'buying the body time,' or 'giving the body some space,' rather than killing the bacteria directly.

If you stop the exposure prematurely, all you've done is delay their growth temporarily, trigger plasmid distribution to ensure even the non-resistant ones are resistant now, all without giving the immune system enough time it needs to crack the denser colonies. It makes things much worse.

As you say: full course is not guaranteed to totally eliminate the gribblies, but it does improve the odds significantly, which is why it's recommended as part of reducing global resistance risk. It's more important if the patient has weak immunity: seniors, seriously ill, &c.


An above poster was asking about whether giving antibiotics for one bacteria can have consequences for resistance in others... that depends firstly on whether the other bacteria are vulnerable to the particular antibiotic's mechanism of action. In this sense wide-spectrum antibiotics are more likely to have cross-impact. It also depends on the location and colonizing properties of the other gribbly. Some systemic antibiotics will not contact integument flora, for example, and vice-versa: topicals may not penetrate, depending on formulation.



Another poster was asking about whether bacteria can be harmless in one location, but harmful in another. To answer this, you have to start by understanding that there shouldn't be bacteria 'inside' the body at any time. The respiratory surface is just a continuation of the skin, as is the bowel, and mucousy regions such as they eye and the urinary tract below the bladder. So these are considered 'outside'. It's normal to find bacteria here, and this is not surprisingly where most infections occur.

If bacteria is present 'inside' the body - meaning in tissues such as muscle, bone, blood, or other organ tissues, the patient has a big problem. The most common way bacteria get from 'outside' to 'inside' is some sort of wound that punctures the integument. Another route is mucous membranes, whose surfaces are unfortunately permeable to particles of this size.

Great post.

Do you happen to know how much the antibiotic effect on normal gut flora (while some antibacterials don't affect the gut, others certainly do) might play into plasmid transfer for resistance development? I've never really thought about this issue because I thought most of the gut flora was left unaffected. Some are obviously hit or we wouldn't see C. diff. overgrowth.

Is this even a legitemate concern?
 
IF they do usually just go back to flora, I can't see how a shorter course is more harmful than a longer course. It seems like the opposite should be true.

There are two reasons you'd want to attack a bacterial infection: either the normal flora has mutated to a pathological strain, or the normal flora has grown out of control.

In the first situation, the antibiotics would have to be aggressive and the goal is to eliminate the last trace of the gribblie. A half-course will be inadequate, and you would simply return to the original pathological situation.

In the second situation, the goal would be to apply antibiotic to buy time for the body to get to work, and the point is that you want the body to get rid of as many as possible to reduce the symptoms, but keeping in mind that resistance is a risk. The unintended side effect of an interrupted course is that yes, the exposure could have been sufficient for the body to get a grip on the overgrowth, but at the cost of not being intense enough to suppress resistance. So, the patient is healthy again, but now carrying a resistant strain. Next time, the patient is not going to respond to the antibiotic, and if there's an immune system problem, there could be grave consequences.

Not to mention the risk that the recovered patient could accidentally pass these resistant bacteria to become the baseline flora for another patient, such as a newborn.
 
Those are almost all over-treated. Those two-week courses, like the seven day courses and the the ten day courses are all made up time periods because the drug trials have to have some set time period for statistical purposes. They always choose a time period that will work for most people but not so long so as to produce increased toxicity, so that the drug looks good. As a consequence the time period is almost always overkill. Then the FDA approves the drug for the treatment of x for two weeks. So, to avoid lawsuits docs use the drug for the treatment of x for 2 weeks.

That's sort of what I thought.
I guess I wonder if antibiotic overkill is more of a problem than 'healthy' people who quit taking their antibiotics sooner than recommended and still recover.
 
That's sort of what I thought.
I guess I wonder if antibiotic overkill is more of a problem than 'healthy' people who quit taking their antibiotics sooner than recommended and still recover.

My immediate reaction would be -- if all the bacteria are killed then there is no possibility for resistance to develop in that person, so as long as they don't have bad side effects you're probably better off with the over-treatment.

But I'm still waiting to hear from Blutoski on the plasmid transfer issue. That part of it is really out of my league. If gut flora aren't affected enough to worry about, then we should be using overkill. Every time.

ETA

Wait, not every time. Not for infections we know we can't eradicate and where some one is left colonized. If the infection can be kept at bay through some other means, then use that instead since resistance will arise in a colonized person.
 
Last edited:
Those are situations where the person gets sick again, though, or stays sick, right?

There could be other reasons. The patient may have a compromised immune system, or different infecting bacteria that cycle, or different strains of the same bacteria.

Incidentally, this is why it is not always a bad idea to prescribe antibiotics for a viral infection: the surface area in question - say, the throat - can become lesioned by a viral infection, and will be very vulnerable to bacterial colonization. A taxed immune system may not be able to react quickly enough, so a common viral infection can become a serious bacterial infection. Administration of prophylactic antibiotics may be important to prevent a much more serious situation. This is especially important for seniors, babies, or the immunocompromised. We don't want a serious throat cold to turn into thrush in a senior who already doesn't eat enough due to reduced appetite - could be fatal.




If the person recovers and doesn't immediately relapse, is an incomplete course more harmful when it comes to resistance than a full course?

Depends on your criteria of 'harmful,' I think. I would say so, due to the greater likelihood of developing a resistant strain. The patient is setting himself up for future problems.

In terms of resistance development, half a course is worse than no course, which is worse than a full course. All or nothing are the only responsible options.

(On this note: I have a penicillin & neomycin allergy, so it's always 'nothing' for me. I had my tonsils removed when I had tonsilitis, because there was no antibiotic option, and it was clearly worsening week after week.)
 
blutoski said:
There are two reasons you'd want to attack a bacterial infection: either the normal flora has mutated to a pathological strain, or the normal flora has grown out of control.
When bacteria is cultured, does anyone ever look for that, though?
For example, I've read about some kind of virulence gene in nontypeable h. influenzae being on the rise right now. I get the impression that as far as "bad bacterial infections" go, that's one of the bigger problems in adult humans at the moment. But when people are cultures to identify the bug causing their infection, that's still not looked for, and there's no way to know from symptoms if it's regular overgrowth, or if they're infected with something with increased virulence.

In the first situation, the antibiotics would have to be aggressive and the goal is to eliminate the last trace of the gribblie. A half-course will be inadequate, and you would simply return to the original pathological situation.
Are you absolutely sure that even with aggressive treatment, even a virulent type doesn't often just go back to acting like flora? For a while, at least?
 
Ich said:
If gut flora aren't affected enough to worry about, then we should be using overkill. Every time.


It's not gut flora I'm thinking of being affected. It's nasopharyngeal flora, since a lot of those species are related and act in similar ways and all can colonize at the same time and share a similar sensitivity to the same antibiotics.
 
When bacteria is cultured, does anyone ever look for that, though?

Sometimes, if it's suspected based on symtoms. Virulent strains would be suspected in an otherwise healthy individual, or if the infection is causing unusual symptoms. Usually, when we say 'virulent,' we mean unusually fast growth, but there could be other reasons the infection is more dangerous than from ordinary strain's overgrowth: the bacteria may be producing a toxin specific to the strain, or it may have a different colonial property, such as a distinctive coating that causes a special immune response, or is more protective (which would explain its higher growth rate). The unusual signs can tip off the doc, and he could instruct the lab to test for unusual strains.



For example, I've read about some kind of virulence gene in nontypeable h. influenzae being on the rise right now. I get the impression that as far as "bad bacterial infections" go, that's one of the bigger problems in adult humans at the moment. But when people are cultures to identify the bug causing their infection, that's still not looked for, and there's no way to know from symptoms if it's regular overgrowth, or if they're infected with something with increased virulence.

No, but your question was about whether infections go back to normal flora once under control, and I was breaking it down to two scenarios because there are different answers. If the patient had wild type strep, but was infected with a pathological strain, then the pathological strain would never 'revert' back to wild type.



Are you absolutely sure that even with aggressive treatment, even a virulent type doesn't often just go back to acting like flora? For a while, at least?

That's what I was getting at: if the reason the patient had problems was that the normal flora was replaced by a pathological strain (either through inoculation from some outside source, or through a bad luck mutation in the colony), then even a temporary reprieve is pointless.
 
The point of medical education isn't to test people, its to teach them how to keep their own butts out of medical trouble, as good as possible. If people refuse to learn, its their own damn fault. Did I mention schools need to be privatized and tests need to be abolished? Well I did now.


ok beyond the fact that the people who didnt pass werent refusing to learn and just couldnt seem to learn it despite trying hard...

and you didnt have anything to say about how a system of multiple people reviewing things is safer...
 
It's not gut flora I'm thinking of being affected. It's nasopharyngeal flora, since a lot of those species are related and act in similar ways and all can colonize at the same time and share a similar sensitivity to the same antibiotics.

OK. I guess I think more in terms of gut and skin flora since the biggie nosocomial infections are Staph. and Enterococcus and we have multiresistant strains of both.

And never mind, Blutoski, I answered my own question with a little search. The answer is "yes". I don't know how much the transfer of plasmid vectors from person to person who have resistant gut strains is, but I would assume in nursing homes it might be quite high.

The good news is that most people don't need to worry about this.
 
Last edited:
OK. I guess I think more in terms of gut and skin flora since the biggie nosocomial infections are Staph. and Enterococcus and we have multiresistant strains of both.

I probably think about pneumococcals and meningococcals and Hi's since I have a kid, and every time he gets a fever I freak out wondering if it's something that will turn into meningitis. :o

I should probably start watching American Idol or something instead of finding new things to be paranoid about. :o
 
blutoski said:
No, but your question was about whether infections go back to normal flora once under control, and I was breaking it down to two scenarios because there are different answers. If the patient had wild type strep, but was infected with a pathological strain, then the pathological strain would never 'revert' back to wild type.

But even most of the most virulent types just clear on their own eventually, right? For reasons that aren't understood?

And you can carry a highly virulent strain for a while and never get an actual "infection" from it?
 
From my personal experience it seems bacteria start getting resistant when the duration of treatment was too short (the infection was not eliminated). Regardless the more time an animal has spent on antibiotics the more likely it will have a resistant strain. Thus if you hit them hard the first time and completely eliminate the infection you end up with a shorter overall length of time on antibiotics and less likely chance of resistance. (my opinion)
 
Last edited:
Kellyb said:
I should probably start watching American Idol or something instead of finding new things to be paranoid about.

What? And catch the Simon meme? I've heard the mutations of that thing can be quite gruesome.
 
Knowing nothing is sometimes better than knowing too little.

Can you give some examples relating to possible life or death scenarios? For some reason I am envisioning things like people just walking straight into a bonfire, off a cliff, or wading in to the ocean over their head, breathing,...or even waking up with their arm asleep in bed and then rolling over onto that 'dead' arm..... and they'll be better off because they know nothing?
 
I was just going to let that comment die the quick and painless death of being buried by new post, but noooooooooooo, you had to bring it back to life.

:(

The stuff about antibiotics is way interesting however. :)
 
Before you all reinforce a few misconceptions in your brains here, I should like to offer some additional factors for consideration.

Ichneumonwasp concludes, "This whole thing is just a numbers game".
...The problem arises when half a course or irregular administration of antibiotics results in organisms sticking around longer and making resistance more likely.

This whole thing is just a numbers game. In fact, there seems to be a sweet spot where resistance is more likely to happen -- it isn't as though whole course/half course is the real issue.

The real issue is how effective the antibiotic course is in eradicating organisms. If it is highly effective then you can't get resistance because all the organisms are gone in that particular body. If they aren't very effective, then resistance won't develop very easily because it won't matter much if the organisms are affected by the antibiotic or not. Any bacteria that develop resistance may be able to stick around longer than the others, but since there are always many other factors at play to kill them (immune system, bacteriophages, other bacteria, etc.) the resistant strains are no more likely to make than the non-resistant strains.

In scenario number one (which does happen) there are no bacteria left to be able to produce variability. In scenario number two there are plenty of bacteria to produce plenty of variability but it doesn't matter much if resistance develops.

Resistance does develop in scenario number three -- where there is a strong selection pressure and there are enough bacteria left around to produce lots of variable strains in which a resistant strain is one possibility. That can happen most easily if you have a highly sensitive bacterium and apply only a relatively mild pressure that works but does not eradicate them all (only taking part of a course of antibiotics) or if you have a bacterium that is not going to be completely eradicated by the antibiotic but is still placed under significant pressure. Resistance is likely to develop only if there are still quite a few bacteria left around to produce a significant degree of variability. If there are only a few bacteria floating around and they are kept in check by the immune system at a very low number, then they are simply not going to produce many copies, so there is less chance of new mutations resulting in resistant strains. With this scenario, the limiting factor is the host's life. The number of possible mutations is a product of the number of organisms and time. Eventually resistance should develop in every case where bacteria are not eradicated completely except for the fact that hosts don't live forever. The bacteria in them usually die with the host (many can survive through other means, though). If there are many bacteria left around and the selection pressure is high, then resistance is going to develop. The speed of development depends on the number of bacteria produced in general. It's [just] a numbers game.

So, I'm afraid it just isn't as simple as half-course/whole-course and you've got an answer. It depends on what type of organism you speak of.
This is correct, sort of, but there are a couple of things left out which do affect the accuracy of the conclusions.

The most important issue left out here that affects the question of a partial course vs completing the course of antibiotics is the fact that the evolution of fluoroquinolone [and a number of other antibiotics] resistance involves the accumulation of multiple mutations in several genes. A partial course of antibiotics can leave any number of partially resistant strains around primed for full resistance the next time.

In addition, while in many cases an infection only ends when the pathogen is eliminated, there are times when the disease process ends but the bacteria, including known pathogens, remain. So taking an incomplete course of antibiotics may make you well while not eliminating the carrier state while a complete course might have eliminated the carrier state.

So for example, the kids with ear infections whose parents aren't as good about getting the kids to swallow the drug, or whose parents repeatedly stop meds when the kids look OK end up with high rates of antibiotic resistant ear infections. The ear disease process subsides but the bacteria remain in the oropharynx primed for drug resistance. Next viral infection which plugs up the eustachian tubes causes another ear infection and this time the bacteria have increased resistance to past antibiotics used.

A third thing to consider is the frequency which a partial course of drugs leads to resistant strains vs the frequency of treatment failure with a full course. If almost all full courses are successful, and partial courses lead to a long drawn out infection, say a UTI, then you get drug resistance developing frequently if you don't complete treatment, and only rarely if you do.

Treating some infections does increase a person's chance of being infected with a drug resistant strain the next time, especially certain antibiotics like the floroquinolones. (Relationship between quinolone use and emergence of ciprofloxacin-resistant Escherichia coli in bloodstream infections.) For this reason you need this information when determining which antibiotic to use first and which to only use if option #1 is not feasible. A patient with an artificial heart valve or one who had clostridium in the past shouldn't get a floroquinolone unless it is the only option. And if you have a patient with e-coli sepsis who has had floroquinolones in the past, that could affect the drug you start them on before the culture sensitivities are back.

And as Ichne pointed out, all sorts of other factors are involved in antibiotic resistance besides just the factor of completing a course of antibiotics or stopping it prematurely. (Development of resistance during antimicrobial therapy: a review of antibiotic classes and patient characteristics in 173 studies.)

One final issue, I have said it before, it is sometimes easy to think of some very complex processes in oversimplified ways. That is often the case with molecular genetics and evolution science. We learned about Mendelian inheritance and survival of the fittest and haven't necessarily found out how much more complicated the actual processes are.

If you are interested in something beyond the basics, these links will expand your understanding and they are guaranteed to confuse all but the genetic scientists and the molecular biologists at least at first.

The role of mutators in the emergence of antibiotic-resistant bacteria.

Evolution of mutation rates in bacteria.

Costs and benefits of high mutation rates: adaptive evolution of bacteria in the mouse gut. (Not that the mouse gut is particularly interesting but this introduces the concept of the point of diminishing returns in the increase and decrease of mutation rates.)

And this is a free full article, Induction and Inhibition of Ciprofloxacin Resistance-Conferring Mutations in Hypermutator Bacteria, which gives you a little more about where the science is going with this particular line of research. We are learning more about the built in genetic variability which has been selected in slowly reproducing organisms, and here we are discovering the mutation rates are affected by a number of variable processes including the efficiency or inefficiency of repair of mutations. That should add some fuel to the Creationist debates arguing mutation rates can't explain the life forms we see on Earth today.

And if that doesn't sound complicated enough, try a few of these terms out:
  • repair of replication forks
  • Spontaneous and mutagen-induced deletions
  • RuvAB branch migration complex can displace topoisomerase
  • repressor protein differentially inhibits the unwinding reactions catalyzed by DNA helicases
  • translesion DNA synthesis in eukaryotes
  • SOS-induced mutagenesis
They are new ones to me I just came across looking this other stuff up. I probably won't bother with them until they come up again and seem pertinent to something new I want to understand.

A little knowledge might be more dangerous than no knowledge if it led you to believe you could just go to that Tiajuana pharmacy and order your own antibiotics based on very incomplete knowledge you believed was complete. If you didn't know anything at all about antibiotics you might not be inclined to believe it was no big deal to prescribe your own.
 
Last edited:

ISF - Join now!

Every member here is approved by hand. No bots, no spam, just people who care about evidence and honest debate.

Membership is free!

Create your free account

Back
Top Bottom